Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Optimized lipid nanoparticles for pulmonary delivery of CRISPR/Cas9 targeting KRAS G12S in lung cancer.

Journal of controlled release : official journal of the Controlled Release Society·2026

Same author

Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial.

BJOG : an international journal of obstetrics and gynaecology·2025

Same author

Polyphosphazene-Based Nanotherapeutics.

Journal of functional biomaterials·2025

Same author

Designing polyphosphazene derivatives for gene delivery in glioblastoma treatment.

Materials today. Bio·2025

Same author

SUMOylation of the lysine-less tumor suppressor p14ARF counters ubiquitylation-dependent degradation.

Cell death & disease·2025

Same journal

Innovative Peptide Formulations for Cardiovascular Diseases Using Supercritical CO<sub>2</sub>: A Comprehensive Review and Potential Applications.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

Same journal

An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

Same journal

Lipid nanoparticles for Cas9 ribonucleoprotein delivery: design and evaluation of ionisable oligoamine-lipidoids.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

Same journal

Synthesis and Biological Evaluation of Novel Carbazole Derivatives as Broad-Spectrum Antibacterial Agents to Fight Antimicrobial Resistance (AMR).

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

Same journal

Rheological Modeling and Torque-Based Processability Prediction for Celecoxib/PVPVA Hot-Melt Extruded Amorphous Solid Dispersions.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

Same journal

Design, synthesis, and biological analysis of aurein 1.2 analogues incorporating fluorinated phenylalanine.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 25, 2026

Co-localization of Cell Lineage Markers and the Tomato Signal

Co-localization of Cell Lineage Markers and the Tomato Signal

Published on: December 28, 2016

Transcript‑activated matrices with optimized mRNA designs to direct chondroblastic lineage commitment.

Héctor Rilo-Alvarez¹, Adriana M Ledo¹, Mónica Lopez²

¹CiMUS Research Center and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Spain; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Universidade de Santiago de Compostela, Spain.

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences

|May 23, 2026

Summary

This summary is machine-generated.

Transcript-Activated Matrices (TAMs) were engineered with optimized mRNA for enhanced SOX9 expression. This improved chondroblastic differentiation in cartilage tissue engineering and defect repair.

Keywords:

Cartilage tissue engineering Fibrin scaffolds Gene-activated matrices Transcript-activated matrices mRNA optimization

More Related Videos

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation

Published on: January 20, 2018

A 5-mC Dot Blot Assay Quantifying the DNA Methylation Level of Chondrocyte Dedifferentiation In Vitro

A 5-mC Dot Blot Assay Quantifying the DNA Methylation Level of Chondrocyte Dedifferentiation In Vitro

Published on: May 17, 2017

Related Experiment Videos

Last Updated: May 25, 2026

Co-localization of Cell Lineage Markers and the Tomato Signal

Co-localization of Cell Lineage Markers and the Tomato Signal

Published on: December 28, 2016

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation

Published on: January 20, 2018

A 5-mC Dot Blot Assay Quantifying the DNA Methylation Level of Chondrocyte Dedifferentiation In Vitro

A 5-mC Dot Blot Assay Quantifying the DNA Methylation Level of Chondrocyte Dedifferentiation In Vitro

Published on: May 17, 2017

Area of Science:

Biomaterials Science
Molecular Biology
Regenerative Medicine

Background:

Cartilage tissue engineering requires controlled modulation of early chondroblastic differentiation.
Transcript-Activated Matrices (TAMs) offer a platform for lineage specification by embedding mRNA in scaffolds.

Purpose of the Study:

To optimize TAM performance by engineering transcript features for enhanced expression magnitude and persistence.
To evaluate the impact of these modifications on chondroblastic programming using SOX9 as a model transcription factor.

Main Methods:

Engineering TAMs with directly transcribed poly(A) tails and chemically modified nucleotides.
Evaluating SOX9 expression and chondroblastic markers (ACAN, COL-X, COL-II) in 3D cultures and a rabbit cartilage defect model.

Main Results:

Optimized TAMs with engineered transcripts increased SOX9 expression 5-40 fold in 3D cultures.
Enhanced chondroblastic programming was observed, with increased ACAN and reduced hypertrophic markers.
TAM implantation in rabbits induced a pro-chondroblastic transcriptional signature, despite minimal early histological changes.

Conclusions:

Rational transcript design significantly enhances TAM performance and provides precise control over early chondroblastic fate.
This transcript-engineered platform shows promise for directing differentiation in tissue engineering applications.